Canal Capital Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Canal Capital Management’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-26,352	Closed	-$744K	–	149
2022 Q4	$744K	Buy	26,352 +340	+1%	+$10.8K	0.18%	89
2022 Q3	$855K	Buy	26,012 +3,226	+14%	+$118K	0.25%	75
2022 Q2	$718K	Buy	22,786 +674	+3%	+$23.6K	0.21%	78
2022 Q1	$1.02M	Sell	22,112 -4,540	-17%	-$216K	0.27%	69
2021 Q4	$1.63M	Buy	26,652 +19,154	+255%	+$1.32M	0.39%	62
2021 Q3	$560K	Buy	7,498 +410	+6%	+$34.4K	0.16%	87
2021 Q2	$656K	Buy	7,088 +412	+6%	+$35K	0.19%	84
2021 Q1	$592K	Sell	6,676 -3,537	-35%	-$351K	0.2%	86
2020 Q4	$952K	Buy	10,213 +725	+8%	+$57.8K	0.36%	66
2020 Q3	$604K	Buy	9,488 +1,902	+25%	+$111K	0.26%	79
2020 Q2	$396K	Hold	7,586	–	–	0.19%	86
2020 Q1	$237K	Buy	+7,586	New	+$253K	0.13%	94

Other funds holding ARKG

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Canal Capital Management's ARKG Position: Q1 2023 in Review

Canal Capital Management sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2023, closing a stake of 26,352 shares — an estimated $744K sold.

Canal Capital Management first reported a position in ARKG in Q1 2020 and held it in 12 quarters. The position peaked at $1.63M in Q4 2021. 297 funds tracked by Wall St. Rank hold ARKG as of Q1 2023.

Canal Capital Management reported no remaining ARK Genomic Revolution ETF position as of Q1 2023 after selling out during the quarter.
Canal Capital Management sold 26,352 ARK Genomic Revolution ETF shares in Q1 2023, an estimated $744K.
Canal Capital Management first reported a position in ARK Genomic Revolution ETF in Q1 2020 and held it in 12 quarters.
Canal Capital Management's ARK Genomic Revolution ETF position peaked at $1.63M in Q4 2021.
297 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2023.

Based on Canal Capital Management's 13F filing for Q1 2023, filed 4 May 2023.